0001209191-20-036045.txt : 20200611
0001209191-20-036045.hdr.sgml : 20200611
20200611182909
ACCESSION NUMBER: 0001209191-20-036045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200611
FILED AS OF DATE: 20200611
DATE AS OF CHANGE: 20200611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BERGER FRANKLIN M
CENTRAL INDEX KEY: 0001273885
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 20958317
MAIL ADDRESS:
STREET 1: 1000 MARINA BLVD
STREET 2: STE 200
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kezar Life Sciences, Inc.
CENTRAL INDEX KEY: 0001645666
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473366145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-822-5600
MAIL ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-11
0
0001645666
Kezar Life Sciences, Inc.
KZR
0001273885
BERGER FRANKLIN M
C/O KEZAR LIFE SCIENCES, INC.
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2020-06-11
4
P
0
100000
5.50
A
784003
D
Shares were purchased in a public offering of the Issuer at a public offering price of $5.50.
/s/ Marc Belsky, Attorney-in-fact
2020-06-11